ID

36569

Descripción

Phase II Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN); ODM derived from: https://clinicaltrials.gov/show/NCT01953055

Link

https://clinicaltrials.gov/show/NCT01953055

Palabras clave

Versiones (2)
  1. 17/1/19 17/1/19 -
  2. 22/5/19 22/5/19 -
Titular de derechos de autor

Sunnybrook Health Sciences Centre

Subido en

22 de mayo de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

SABR in High Risk Prostate Cancer (SATURN) NCT01953055

Inglés

Eligibility Criteria

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent obtained
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
men > 18 years of age
Descripción

Age and Gender

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
histologically confirmed prostate adenocarcinoma (centrally reviewed)
Descripción

histologically confirmed prostate adenocarcinoma (centrally reviewed)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0679557
UMLS CUI [1,2]
C0007112
high risk prostate cancer, defined as at least one of clinical stage T3 or Gleason 8-10, or PSA > 20ng/ml
Descripción

prostate cancer risk assessment, by clinical T stage, Gleason Score, or PSA

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0086930
UMLS CUI [2]
C3258246
UMLS CUI [3]
C0332326
UMLS CUI [4]
C0138741
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior pelvic radiotherapy
Descripción

prior pelvic radiotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1536155
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
Descripción

anticoagulation medication (if unsafe to discontinue for gold seed insertion)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003280
UMLS CUI [1,2]
C1548265
UMLS CUI [2]
C4040254
diagnosis of bleeding diathesis
Descripción

bleeding diathesis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005779
large prostate (>90cm³) on imaging at time of gold seed insertion
Descripción

prostate size on imaging at seed insertion

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1287816
UMLS CUI [2,1]
C2348792
UMLS CUI [2,2]
C4040254
no evidence of castrate resistance (defined as psa < 3ng/ml while testosterone is < 0.7nmol/l)
Descripción

no evidence of castrate resistance (defined by PSA and testosterone)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C4270759
UMLS CUI [2]
C0201544
UMLS CUI [3]
C0428413
definitive regional or distant metastatic disease on staging investigations
Descripción

definitive regional or distant metastatic disease on staging investigations

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1275402
UMLS CUI [2,1]
C0205147
UMLS CUI [2,2]
C0027627
Volver a la parte superior de la página

Similar models

Eligibility Criteria

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
informed consent obtained
boolean
C0021430 (UMLS CUI [1])
Age and Gender
Item
men > 18 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
histologically confirmed prostate adenocarcinoma (centrally reviewed)
Item
histologically confirmed prostate adenocarcinoma (centrally reviewed)
boolean
C0679557 (UMLS CUI [1,1])
C0007112 (UMLS CUI [1,2])
prostate cancer risk assessment, by clinical T stage, Gleason Score, or PSA
Item
high risk prostate cancer, defined as at least one of clinical stage T3 or Gleason 8-10, or PSA > 20ng/ml
boolean
C0600139 (UMLS CUI [1,1])
C0086930 (UMLS CUI [1,2])
C3258246 (UMLS CUI [2])
C0332326 (UMLS CUI [3])
C0138741 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
prior pelvic radiotherapy
Item
prior pelvic radiotherapy
boolean
C1514463 (UMLS CUI [1,1])
C1536155 (UMLS CUI [1,2])
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
Item
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
boolean
C0003280 (UMLS CUI [1,1])
C1548265 (UMLS CUI [1,2])
C4040254 (UMLS CUI [2])
bleeding diathesis
Item
diagnosis of bleeding diathesis
boolean
C0005779 (UMLS CUI [1])
prostate size on imaging at seed insertion
Item
large prostate (>90cm³) on imaging at time of gold seed insertion
boolean
C1287816 (UMLS CUI [1])
C2348792 (UMLS CUI [2,1])
C4040254 (UMLS CUI [2,2])
no evidence of castrate resistance (defined by PSA and testosterone)
Item
no evidence of castrate resistance (defined as psa < 3ng/ml while testosterone is < 0.7nmol/l)
boolean
C0332197 (UMLS CUI [1,1])
C4270759 (UMLS CUI [1,2])
C0201544 (UMLS CUI [2])
C0428413 (UMLS CUI [3])
definitive regional or distant metastatic disease on staging investigations
Item
definitive regional or distant metastatic disease on staging investigations
boolean
C1275402 (UMLS CUI [1])
C0205147 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial